Global and regional mortality statistics of nipah virus from 1994 to 2023: a comprehensive systematic review and meta-analysis

Revision as of 00:32, 7 February 2026 by Nhmkerala (talk | contribs) (Created paper page - 2026-02-07T06:02:07.366678)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)

Authors: Srivatsa Surya Vasudevana, Arun Subashb, Fena Mehtac, Tiba Yamin Kandrikard, Rupak Desaie, Kaif Khan, Sneha Khandujag, Aakanksha Pitliyah, Lekhya Raavii, Sai Gautham Kanagalaj, Piyush Gondaliyak

Year: 2024

Journal: Pathogens and Global Health

DOI: 10.1080/20477724.2024.2380131

Summary

This paper reports a significant increase in the global mortality rate of Nipah virus from 54.1% (2004–2013) to 80.1% (2014–2023). India has the highest mortality rate at 82.7% (1994–2023), and encephalitis is the primary cause of death.

Key Findings

  • Global mortality rate of Nipah virus in 2014–2023 is 80.1%
  • Mortality rate increased by 24% from the preceding decade (2004–2013)
  • India has the highest mortality rate at 82.7% (1994–2023)
  • Encephalitis accounts for 95% of Nipah virus-related deaths

Methodology

  • Study Type: Systematic Review and Meta-Analysis
  • Sample Size: 2736 NiV patients
  • Geographic Focus: Multiple countries
  • Time Period: 1994–2023

Topics

Epidemiology, Clinical

Relevance

This paper contributes to understanding the increasing mortality rate of Nipah virus, highlighting public health challenges and potential areas for intervention.

Source

PDF Document